These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10269762)

  • 1. Drug usage guidelines, Part 2: Analysis of program outcome.
    Patry RA; Huber SL; Hudson HD; Godwin HN
    Hosp Formul; 1985 Jan; 20(1):57-60. PubMed ID: 10269762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strengthening the formulary system by implementing a drug usage guidelines program.
    Huber SL; Patry RA; Hudson HD; Godwin HN
    Hosp Formul; 1984 Aug; 19(8):664-8. PubMed ID: 10267390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug usage guidelines, Part 3: assessment of acceptance of the program.
    Patry RA; Huber SL; Rice G; Hudson HD; Godwin HN
    Hosp Formul; 1985 Apr; 20(4):464, 470-4. PubMed ID: 10270728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P & T Committee interview: strategies to ensure an effective formulary system.
    Riff L; Hutchinson R
    Hosp Formul; 1988 Nov; 23(11):901-4, 907-8. PubMed ID: 10290754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
    Benner EJ; Mykita L; Brown K
    Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASHP guidelines on formulary system management.
    Am J Hosp Pharm; 1992 Mar; 49(3):648-52. PubMed ID: 1598948
    [No Abstract]   [Full Text] [Related]  

  • 10. P & T Committee interview: Establishing and maintaining a dynamic formulary.
    Rostand S; Lazarus H
    Hosp Formul; 1988 Jan; 23(1):48-53. PubMed ID: 10285373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for deleting popular drugs from a hospital formulary.
    Lemay AP; Salzer LB; Visconti JA; Latiolais CJ
    Am J Hosp Pharm; 1981 Apr; 38(4):506-10. PubMed ID: 7282675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
    Segal R; Pathak DS
    Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P & T Committee formulary requests: criteria for admission.
    Weintraub M; Guttmacher L
    Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P & T Committee interview: communication and education contribute to an effective formulary system.
    Hinthorn D; Godwin H
    Hosp Formul; 1989 May; 24(5):281-4, 286-7. PubMed ID: 10292977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
    Green JA; Chawla AK; Fong PA
    Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing an effective P & T Committee, Part 2.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving an effective committee through reorganization: the Ohio State University Hospital's experience.
    Lewis RP; Moore TD
    Hosp Formul; 1991 Feb; 26(2):120-30. PubMed ID: 10109143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving rational therapeutics through consensus-based protocols and follow-up.
    Quintiliani R; Gousse GC; Chow MS
    Hosp Formul; 1990 Mar; 25(3):283-4, 289-94. PubMed ID: 10103836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P & T Committee interview: Promoting rational drug use.
    Hunt TK; Herfindal ET
    Hosp Formul; 1988 Apr; 23(4):359-62, 365-6, 369. PubMed ID: 10286839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.